Combining moderators to identify clinical profiles of patients who will, and will not, benefit from aripiprazole augmentation for treatment resistant late-life major depressive disorder. uri icon

authors

  • Smagula, Stephen F
  • Lotrich, Francis E
  • Dew, Mary Amanda
  • Reynolds, Charles F
  • Wallace, Meredith L
  • Anderson, Stewart J
  • Karp, Jordan F
  • Lenze, Eric J
  • Mulsant, Benoit H
  • Butters, Meryl A
  • Blumberger, Daniel M
  • Breno Diniz

publication date

  • July 7, 2016